New Advances

FDA Acne Recall, AAD Benzene Warning

Summary The FDA initiated a limited recall of certain acne products due to benzene contamination. The AAD released a statement acknowledging the ongoing research and advising on safe benzoyl peroxide practices. This article explores these […]

New Advances

Calyxo Device Alert

Summary The FDA issued an early alert concerning Calyxo’s CVAC aspiration system following a reported death. The issue arises with patients possessing thick kidney fluid, causing reduced outflow and potentially fatal pressure buildup. Calyxo has […]

New Advances

Smiths Medical Recalls, Issues Warning

Summary Smiths Medical has recalled implantable ports due to a manufacturing defect, posing risks such as therapy interruption and air embolism. The company also issued a warning about undersized endotracheal tubes, potentially causing inadequate ventilation. […]

New Advances

RSV Vaccine Warning

Summary The FDA mandates Guillain-Barré Syndrome warnings for RSV vaccines Abrysvo and Arexvy. Post-marketing data revealed a potential increased risk of GBS within 42 days of vaccination, though a causal link remains unestablished. The FDA […]

New Advances

J&J’s $55 Billion Boost

Summary Johnson & Johnson is investing $55 billion in US manufacturing, R&D, and technology over the next four years. This investment includes three new manufacturing facilities and the expansion of existing sites, creating thousands of […]

New Advances

Heart Tech Breakthrough: $53M Funding

Summary Cardiac Dimensions secures $53M to finalize a U.S. pivotal study and commercialize its groundbreaking Carillon Mitral Contour System. This minimally invasive device offers a novel approach to treating functional mitral regurgitation (FMR) in heart […]

New Advances

Tricuspid Valve Breakthrough

Summary Laplace Interventional secures $22M in Series C funding to advance its minimally invasive tricuspid valve replacement technology. This funding will propel the completion of their Early Feasibility Study and pave the way for a […]

New Advances

Hemodialysis Crisis: A Looming Threat

Summary The FDA has added hemodialysis devices to its shortage list, anticipating the scarcity to persist until fall 2025. This shortage stems from supplier disruptions, notably at B. Braun, impacting the availability of essential bloodlines. […]

New Advances

EPA Rethinks Sterilizer Emissions

Summary The EPA is reevaluating emission standards for medical device sterilizers, balancing public health with the need for sterilized equipment. This reconsideration comes as sterilization technology advances, impacting both the environment and healthcare practices. The […]